ITTO20110633A1 - Metodo per trattare il morbo di alzheimer - Google Patents

Metodo per trattare il morbo di alzheimer

Info

Publication number
ITTO20110633A1
ITTO20110633A1 IT000633A ITTO20110633A ITTO20110633A1 IT TO20110633 A1 ITTO20110633 A1 IT TO20110633A1 IT 000633 A IT000633 A IT 000633A IT TO20110633 A ITTO20110633 A IT TO20110633A IT TO20110633 A1 ITTO20110633 A1 IT TO20110633A1
Authority
IT
Italy
Prior art keywords
alzheimer
dead
treat
Prior art date
Application number
IT000633A
Other languages
English (en)
Italian (it)
Inventor
Oleg Iliich Epshtein
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44863153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITTO20110633(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010130353/15A external-priority patent/RU2542445C2/ru
Priority claimed from RU2011127058/15A external-priority patent/RU2536232C2/ru
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Publication of ITTO20110633A1 publication Critical patent/ITTO20110633A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507Comprising a combination of two or more separate antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT000633A 2010-07-21 2011-07-15 Metodo per trattare il morbo di alzheimer ITTO20110633A1 (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2010130353/15A RU2542445C2 (ru) 2010-07-21 2010-07-21 Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
RU2011127058/15A RU2536232C2 (ru) 2011-07-01 2011-07-01 Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера

Publications (1)

Publication Number Publication Date
ITTO20110633A1 true ITTO20110633A1 (it) 2012-01-22

Family

ID=44863153

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000633A ITTO20110633A1 (it) 2010-07-21 2011-07-15 Metodo per trattare il morbo di alzheimer

Country Status (16)

Country Link
US (1) US20130058982A1 (OSRAM)
EP (1) EP2596021A2 (OSRAM)
JP (1) JP2013535445A (OSRAM)
CN (1) CN103119060A (OSRAM)
AU (1) AU2011281252A1 (OSRAM)
CA (1) CA2805943A1 (OSRAM)
DE (1) DE112011102409T5 (OSRAM)
EA (1) EA029399B1 (OSRAM)
FR (1) FR2962912A1 (OSRAM)
GB (1) GB2496801B (OSRAM)
IT (1) ITTO20110633A1 (OSRAM)
MX (1) MX2013000808A (OSRAM)
NZ (1) NZ606969A (OSRAM)
PH (1) PH12013500143A1 (OSRAM)
UA (1) UA107836C2 (OSRAM)
WO (1) WO2012010978A2 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
EP2593474A2 (en) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
DE112011102349T5 (de) 2010-07-15 2013-04-18 Oleg Iliich Epshtein Pharmazeutische Zusammensetzung und Behandlungsverfahren
CZ2013105A3 (cs) * 2010-07-15 2013-05-22 Iliich Epshtein@Oleg Zpusob zvýsení úcinku aktivované potencované formy protilátky
WO2012010970A2 (en) 2010-07-21 2012-01-26 Oleg Iliich Epshtein A method of treating attention deficit hyperactivity disorder
BR112013001296A2 (pt) * 2010-07-21 2017-12-19 Lliich Epshtein Oleg composições farmacêuticas e respectivo uso e métodos de tratamento de vertigem de diferentes origens, cinetose e distonia vascular vegetativa
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
CN104324359B (zh) * 2014-09-25 2016-08-17 中山大学 Rry三肽在制备治疗阿尔茨海默症药物中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
RU2156621C1 (ru) 1999-03-04 2000-09-27 Эпштейн Олег Ильич Нейротропное лекарственное средство
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
AU2002258518A1 (en) * 2001-03-14 2002-09-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
US6451547B1 (en) * 2001-04-25 2002-09-17 Syn X Pharma Process for differential diagnosis of Alzheimer's dementia and device therefor
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
JP2006516089A (ja) * 2002-10-02 2006-06-22 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法
TWI345470B (en) 2003-03-14 2011-07-21 Nutrition Res Inc Homeopathic formulations useful for treating pain and/or inflammation
BRPI0601496B8 (pt) * 2006-04-13 2021-05-25 Miria De Amorim composições medicamentosas, uso das mesmas, kits medicamentosos e método de aplicação das composições medicamentosas
BR112013001296A2 (pt) * 2010-07-21 2017-12-19 Lliich Epshtein Oleg composições farmacêuticas e respectivo uso e métodos de tratamento de vertigem de diferentes origens, cinetose e distonia vascular vegetativa

Also Published As

Publication number Publication date
CN103119060A (zh) 2013-05-22
DE112011102409T5 (de) 2013-07-04
AU2011281252A1 (en) 2013-03-07
NZ606969A (en) 2015-08-28
GB201302929D0 (en) 2013-04-03
EA029399B1 (ru) 2018-03-30
WO2012010978A3 (en) 2012-04-26
PH12013500143A1 (en) 2019-09-02
GB2496801A (en) 2013-05-22
GB2496801B (en) 2018-04-11
EA201300130A1 (ru) 2013-12-30
EP2596021A2 (en) 2013-05-29
UA107836C2 (uk) 2015-02-25
CA2805943A1 (en) 2012-01-26
MX2013000808A (es) 2013-10-28
JP2013535445A (ja) 2013-09-12
WO2012010978A2 (en) 2012-01-26
FR2962912A1 (fr) 2012-01-27
US20130058982A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
ITTO20110633A1 (it) Metodo per trattare il morbo di alzheimer
SMT201600375B (it) Procedimento per la produzione di estetrolo
EP2707510A4 (en) ISOLATION OF NUCLEIC ACIDS
BR112014006324A2 (pt) método para tratar hcv
DK3104617T3 (da) Fremgangsmåde til at entropiafkode transformationskoefficienter
PT2774122T (pt) Método de gerar bloco reconstruído
HUE041891T2 (hu) Berendezés ipari célokra használt víz kezelésére
IL233089A0 (en) Methods for improving medical therapies
BR112014006702A2 (pt) método para tratar osteoporose
PL2744519T3 (pl) Kompozycje odmładzające do skóry
SMT201600001B (it) Imidazopiridazine come inibitori di akt chinasi
PL3299356T3 (pl) Sposób wytwarzania pleuromutylin
BR112013008528A2 (pt) métodos para tratar psoríase
BR112014009785A2 (pt) método para tratar ou reduzir efp
FI20106048A0 (fi) Kieliprofiloinnin menetelmä
PL2688948T3 (pl) Sposób otrzymywania roztworu przyspieszacza
BR112012018086A2 (pt) método para gerar vapor d'água
EP2709665A4 (en) TREATMENT OF PSORIASIS
LT3202769T (lt) Fosfaplatinos junginių gryninimo būdas
BR112012022525A2 (pt) método para produzir butanol
DK2680390T4 (da) Fremgangsmåde til strømregulering
PL3536410T3 (pl) Metoda przetwarzania odpadów
LT3404041T (lt) Osteoporozės gydymo būdas
BR112014008845A2 (pt) processo de tratamento anticorrosão
FI20116093L (fi) Vettä käsittelevä laitos